genelabs(gnlb) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : genelabs(gnlb)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Chisy who wrote (159)	12/7/1999 1:39:00 AM
From: Toni Wheeler	Read Replies (1) of 233

Chisy, Nothing, that we KNOW of, is any different since the 11/22 Press Release: Genelabs ready to file NDA for lupus drug <<<REDWOOD CITY, Calif., Nov 22 (Reuters) - Genelabs Technologies Inc. (NASDAQ: GNLB) said Monday that the U.S. Food and Drug Administration has agreed that its New Drug Application proposal for its lupus drug appears adequate for submission. The company said that GL701, its investigational drug for systemic lupus erythematosus (SLE), demonstrated a statistically significant advantage over placebo according to some analyses in patients with active disease. Genelabs noted that if approved, GL701 would be the first new drug approved for people with SLE in the past 40 years.>>> Patiently waiting for news, T.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next